41395-10-2

Basic information

• Product Name: Benzene, 1,3-dimethoxy-5-propyl-
• CAS NO: 41395-10-2
• Molecular Formula: C11H16O2
• Molecular Weight: 180.247
• Mol File: 41395-10-2.mol
• Article Data: 20

Chemical Properties

• CAS DataBase Reference: Benzene, 1,3-dimethoxy-5-propyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,3-dimethoxy-5-propyl-(41395-10-2)
• EPA Substance Registry System: Benzene, 1,3-dimethoxy-5-propyl-(41395-10-2)

Safety Data

• Hazardous Substances Data: 41395-10-2(Hazardous Substances Data)

Upstream product

• 55136-70-4 3-methoxy-5-propylphenol 
• 74-88-4 methyl iodide 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 925-90-6 ethylmagnesium bromide 
• 6627-88-9 4-allyl-2,6-dimethoxyphenol 
• 17745-45-8 propylboronic acid 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 155586-39-3 (3,5-dimethoxyphenyl)-N-methoxy-N-methylcarboxamide 
• 126395-78-6 3,5-dimethoxy-1-propylcyclohexa-2,5-diene-1-carboxylic acid 
• 54132-76-2 3,5-dimethoxyphenyl isocyanate 
• 10272-07-8 3.5-dimethoxyaniline 
• 72470-95-2 3,5-dimethoxybenzenediazonium tetrafluoroborate 
• 52189-63-6 3,5-dimethoxyfluorobenzene 
• 51707-38-1 3,5-dimethoxy-benzoic acid hydrazide 

Downstream Products

• 1132-21-4 3,5-dimethoxybenzoic acid 
• 1197155-73-9 1,5-dimethoxy-3-propylcyclohexa-1,4-diene 
• 28172-17-0 (6aS,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol 
• 24274-48-4 cannabidivarin 
• 156028-13-6 6,6'-di-n-propyl-2,2',4,4'-tetramethoxydiphenylmethane 
• 31262-38-1 3-norpentyl-3-propyl-Δ⁸-tetrahydrocannabinol 
• 192211-99-7 acremonisol A 
• 192212-00-3 3-Chloro-4,6-dimethoxy-2-propyl-benzoic acid methyl ester 
• 192212-02-5 3-Chloro-6-hydroxy-4-methoxy-2-propyl-benzoic acid methyl ester 

Relevant articles and documents

A Novel and Practical Continuous Flow Chemical Synthesis of Cannabidiol (CBD) and its CBDV and CBDB Analogues

Cannabidiol is one of the main non-psychoactive cannabinoids present in Cannabis sativa and, in the last decade, it is gaining great interest among the scientific community for its pharmaceutical, nutraceutical, and cosmetic applications. Herein, we report the first continuous flow chemical synthesis of cannabidiol (CBD) and its analogues cannabidivarin (CBDV) and cannabidibutol (CBDB). This approach permits to synthesize products in very good yields (55–59 %), limiting the formation of psychoactive and illegal cannabinoids such as tetrahydrocannabinol (THC).

Using (+)-carvone to access novel derivatives of (+)-ent-cannabidiol: The first asymmetric syntheses of (+)-ent-CBDP and (+)-ent-CBDV

(?)-Cannabidiol [(?)-CBD] has recently gained prominence as a treatment for neuro-inflammation and other neurodegenerative disorders; interest is also developing in its synthetic enantiomer, (+)-CBD, which has a higher affinity to CB1/CB2 receptors than the natural stereoisomer. We have developed an inexpensive, stereoselective route to access ent-CBD derivatives using (+)-carvone as a starting material. In addition to (+)-CBD, we report the first syntheses of (+)-cannabidivarin, (+)-cannabidiphorol as well as C-6/C-8 homologues.

CANNABINOID DERIVATIVES

This disclosure relates to cannabinoid derivatives of formula (I), pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives in treating or preventing a diseases associated with a cannabinoid receptor in a subject in ne